| Abstrakt: |
Keywords: Antineoplastics; Drugs and Therapies; EGFR Inhibitors; HER2 Inhibitors; Health and Medicine; Lapatinib Therapy; Pharmaceuticals; Tyrosine Kinase Inhibitors EN Antineoplastics Drugs and Therapies EGFR Inhibitors HER2 Inhibitors Health and Medicine Lapatinib Therapy Pharmaceuticals Tyrosine Kinase Inhibitors 1560 1560 1 10/30/23 20231103 NES 231103 2023 NOV 3 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- A new study on antineoplastics is now available. Keywords for this news article include: Department of Pharmaceutical Chemistry, Antineoplastics, Pharmaceuticals, EGFR Inhibitors, HER2 Inhibitors, Lapatinib Therapy, Drugs and Therapies, Health and Medicine, Tyrosine Kinase Inhibitors. [Extracted from the article] |
